PDGFR-A is a therapeutic target in alveolar rhabdomyosarcoma. [electronic resource]
Producer: 20081208Description: 6550-60 p. digitalISSN:- 1476-5594
- Animals
- Antineoplastic Agents -- therapeutic use
- Benzamides
- Cell Line, Tumor
- Cells, Cultured
- Genes, p16
- Humans
- Imatinib Mesylate
- Mice
- Mice, Knockout
- Muscle Neoplasms -- drug therapy
- Piperazines -- therapeutic use
- Protein Kinase Inhibitors -- therapeutic use
- Pyrimidines -- therapeutic use
- Receptor, Platelet-Derived Growth Factor alpha -- antagonists & inhibitors
- Rhabdomyosarcoma, Alveolar -- drug therapy
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.